Laza Medical
Laza Medical, a Shifamed portfolio company in Los Gatos, California, develops an AI-powered robotic ultrasound imaging system with a real-time AI heart model for structural heart and electrophysiology procedures in the cath lab, aiming to extend specialist-level imaging expertise.
Position in SVTRnew
Snapshot 2026-11-05- Startup SignalsTop 25%
- Life SciencesTop 25%
- Medtech Device#3of 49
- Medical Imaging#2of 16
About
Laza Medical, a Shifamed portfolio company in Los Gatos, California, develops an AI-powered robotic ultrasound imaging system with a real-time AI heart model for structural heart and electrophysiology procedures in the cath lab, aiming to extend specialist-level imaging expertise. The system is under development and not approved for commercial sale.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Company· 2
Investor· 4
Founders / team· 2
Funding history
- 2026-11-04Series B$160M
Investors · GE HealthCare, Unorthodox Ventures, PA MedTech, AMEDSource · prnewswire.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Laza Medical
Laza Medical, a Shifamed portfolio company in Los Gatos, California…
Series B · 2026-11
—
United States
BusinessLatest roundTotal raisedDate- Promaxo
In-office low-field MRI, AI and robotics platform for prostate diagnosis and treatment
Equity + Debt · 2026-10
— - Dopl Technologies
Hardware-agnostic teleoperated robotic ultrasound system
Seed · $8M · 2026-07
$8M - Monteris Medical
Develops robotically controlled, MR-guided laser ablation systems for minimally invasive brain surgery
Series D+ · $178M · 2026-03
$178M
China
BusinessLatest roundTotal raisedDate- 睿心医疗
Developer of AI precision diagnosis and treatment platforms for cardiovascular and cerebrovascular disease and of vascular interventional surgical rob…
Strategic · 2026-07
— - Krinwave
Super-resolution ultrasound imaging systems (kOS ultrasound operating system + HUS hardware platform)…
Undisclosed · 2026-10
— - 湾影科技
Brain metabolic imaging technology
Undisclosed · 2026-07
—
Europe
BusinessLatest roundTotal raisedDate- Vitestro
Developed a device that integrates AI with ultrasound imaging and robotics to automate blood collection
Series B · $120M · 2026-03
$120M - Nami Surgical
Miniature ultrasonic medical devices for surgery; high-performance small ultrasonic scalpels designed to overcome obstacles in robot-assisted surgery
Undisclosed · $4M · 2024-05
$4M - Soundsafe Care
Robotic focused ultrasound devices for noninvasive tumor ablation, launching first with veterinary certification…
$2M
$2M
Other / unspecified
BusinessLatest roundTotal raisedDate- Scopia Surgical
AI surgical navigation software combining real-time spatial intelligence and patient-specific digital twins for robot-assisted and minimally invasive …
Pre-Seed · $3M · 2026-09
$3M - UltraSight
AI-guided cardiac ultrasound workflow platform (Echosystem) enabling non-specialist clinicians to perform diagnostic-grade echocardiograms at the beds…
Series B · $42M · 2026-09
$42M - IMeditech
R&D and manufacturing of electrospun nanofiber wound care devices, vascular stents, catheters and neurointerventional devices…
$1.1B
$1.1B
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Y Combinator
39 Life Sciences deals in the last 24 months · 21 at a nearby stage · 32 in Silicon Valley
Request intro →General Catalyst
38 Life Sciences deals in the last 24 months · 21 at a nearby stage · 34 in Silicon Valley
Request intro →Andreessen Horowitz
22 Life Sciences deals in the last 24 months · 13 at a nearby stage · 20 in Silicon Valley
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 11 at a nearby stage · 20 in Silicon Valley
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 12 at a nearby stage · 15 in Silicon Valley
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 10 at a nearby stage · 14 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.